Department of Immunology, Erasmus MC, University Medical Center Rotterdam, Rotterdam, the Netherlands.
Haematologica. 2013 Aug;98(8):1173-84. doi: 10.3324/haematol.2012.082156.
Aberrant recombination between T-cell receptor genes and oncogenes gives rise to chromosomal translocations that are genetic hallmarks in several subsets of human T-cell acute lymphoblastic leukemias. The V(D)J recombination machinery has been shown to play a role in the formation of these T-cell receptor translocations. Other, non-T-cell receptor chromosomal aberrations, such as SIL-TAL1 deletions, have likewise been recognized as V(D)J recombination associated aberrations. Despite the postulated role of V(D)J recombination, the extent of the V(D)J recombination machinery involvement in the formation of T-cell receptor and non-T-cell receptor aberrations in T-cell acute lymphoblastic leukemia is still poorly understood. We performed a comprehensive in silico and ex vivo evaluation of 117 breakpoint sites from 22 different T-cell receptor translocation partners as well as 118 breakpoint sites from non-T-cell receptor chromosomal aberrations. Based on this extensive set of breakpoint data, we provide a comprehensive overview of T-cell receptor and oncogene involvement in T-ALL. Moreover, we assessed the role of the V(D)J recombination machinery in the formation of chromosomal aberrations, and propose an up-dated mechanistic classification on how the V(D)J recombination machinery contributes to the formation of T-cell receptor and non-T-cell receptor aberrations in human T-cell acute lymphoblastic leukemia.
T 细胞受体基因和癌基因之间的异常重组导致染色体易位,这是几种人类 T 细胞急性淋巴细胞白血病亚型的遗传标志。已经表明,V(D)J 重组机制在这些 T 细胞受体易位的形成中发挥作用。其他非 T 细胞受体染色体异常,如 SIL-TAL1 缺失,同样被认为是与 V(D)J 重组相关的异常。尽管假设 V(D)J 重组起作用,但 V(D)J 重组机制在 T 细胞急性淋巴细胞白血病中 T 细胞受体和非 T 细胞受体异常形成中的参与程度仍知之甚少。我们对来自 22 个不同 T 细胞受体易位伙伴的 117 个断点和来自非 T 细胞受体染色体异常的 118 个断点进行了全面的计算机模拟和体外评估。基于这组广泛的断点数据,我们全面概述了 T 细胞受体和癌基因在 T-ALL 中的作用。此外,我们评估了 V(D)J 重组机制在染色体异常形成中的作用,并提出了一个更新的机制分类,说明 V(D)J 重组机制如何有助于人类 T 细胞急性淋巴细胞白血病中 T 细胞受体和非 T 细胞受体异常的形成。